Why WJ-MSC Exosomes?
Cell-Derived Precision
Exosomes from Wharton's Jelly mesenchymal stem cells carry targeted biological signals that communicate directly with your cells, supporting natural repair processes at the molecular level.
Biological Messaging
These nano-sized vesicles deliver regenerative instructions to damaged tissue, modulating inflammation and promoting healing without introducing live cells into your body.
Non-Invasive Sourcing
Harvested ethically from donated umbilical cord tissue, WJ-MSC exosomes offer a cell-free approach to regenerative medicine with minimal immune response and maximum therapeutic potential.
Conditions We Treat
One source. Multiple healing pathways.
Frequently Asked Questions
Evidence-based answers about WJ-MSC Exosome therapyView All FAQs →
WJ-MSC Exosomes are extracellular vesicles derived from Wharton's Jelly mesenchymal stem cells. These nano-sized particles contain bioactive molecules including proteins, lipids, and nucleic acids that facilitate cell-to-cell communication and may support tissue regeneration through paracrine signaling mechanisms.
Unlike traditional stem cell therapy which involves living cells, exosome therapy is cell-free. Exosomes are the signaling molecules secreted by stem cells. This cell-free approach may offer a different safety profile and mechanism of action, focusing on paracrine signaling rather than cell engraftment.
Research is exploring WJ-MSC Exosome applications across multiple areas including metabolic conditions like diabetes, cardiovascular health, orthopedic and musculoskeletal concerns, neurological conditions, and inflammatory disorders. Each application is in various stages of investigation.
WJ-MSC Exosome therapy is investigational and not approved by the FDA as a treatment for any specific condition. This therapy is being offered under regulatory pathways that permit the use of investigational products. It is not a cure or approved medical treatment.
Administration methods vary based on the specific protocol and target area. Common delivery routes include intravenous infusion for systemic distribution, localized injection for targeted areas, and other specialized delivery methods determined by the treating physician based on individual assessment.
Candidacy is determined through a comprehensive evaluation process that includes medical history review, current health status assessment, and specific eligibility criteria. Please complete our candidacy evaluation form or contact our team directly to begin the assessment process.
Clinical Research
Peer-reviewed evidence across multiple conditions
DIABETIC FOOT ULCER
WJ-MSC exosomes accelerated epithelial regeneration and reduced inflammatory markers in chronic non-healing wounds.
↑ Wound closure rate
MYOCARDIAL INFARCTION (MI)
Post-infarct application improved cardiac output and reduced scar tissue formation in preclinical and early clinical models.
↑ Ejection fraction
OSTEOARTHRITIS
Intra-articular delivery attenuated cartilage degradation and modulated synovial inflammation across multiple joint sites.
↓ Pain scores
AUTISM SPECTRUM DISORDER
Exosome therapy correlated with measurable gains in adaptive behavior, language acquisition, and social responsiveness.
↑ Social communication scores
Kelton Komprehensive
Conditions We Treat
WJ-MSC Exosomes are being investigated for their regenerative potential across a spectrum of conditions involving inflammation, immune dysregulation, neurological damage, and impaired tissue repair.
Inflammatory & Autoimmune Conditions
Rheumatoid arthritis, Crohn's disease, ulcerative colitis, lupus, multiple sclerosis, and other inflammatory or autoimmune disorders.
Neurological & Neurodegenerative Conditions
Alzheimer's disease, Parkinson's disease, traumatic brain injury, stroke, spinal cord injury, and peripheral neuropathy.
Musculoskeletal & Joint Conditions
Osteoarthritis, tendon injuries, ligament damage, cartilage degeneration, and chronic joint pain.
Cardiovascular Conditions
Heart failure, myocardial infarction, peripheral artery disease, and conditions involving vascular damage or ischemia.
Metabolic & Endocrine Conditions
Type 1 and Type 2 diabetes, metabolic syndrome, obesity-related inflammation, and diabetic complications such as neuropathy or nephropathy.
Dermatological Conditions
Chronic wounds, diabetic ulcers, burns, psoriasis, eczema, scleroderma, and other skin conditions involving impaired healing or chronic inflammation.
Respiratory Conditions
Chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and acute respiratory distress syndrome (ARDS).
Liver & Kidney Conditions
Liver fibrosis, cirrhosis, non-alcoholic fatty liver disease (NAFLD), chronic kidney disease, and acute kidney injury.
Ocular Conditions
Macular degeneration, glaucoma, diabetic retinopathy, and optic nerve damage.
Cancer & Oncology Support
Investigational applications in cancer treatment, tumor microenvironment modulation, and mitigation of treatment-related side effects.
Conditions We Treat
WJ-MSC Exosomes are being investigated for their regenerative potential across a spectrum of conditions involving inflammation, immune dysregulation, neurological damage, and impaired tissue repair.
Inflammatory & Autoimmune Conditions
Neurological & Neurodegenerative Conditions
Musculoskeletal & Joint Conditions
Cardiovascular Conditions
Conditions We Treat
Explore the diverse range of conditions that may benefit from investigational WJ-MSC Exosome therapy.
Chronic Pain
Investigating therapeutic potential for inflammatory and neuropathic pain conditions.
Autoimmune Disorders
Supporting research into immune regulation and systemic inflammation.
Neurological Conditions
Exploring neuroprotective and regenerative pathways for neural health.
Wound Healing
Advancing tissue repair and regeneration for acute and chronic wounds.
Cardiovascular Health
Investigating vascular repair and cardiac regenerative mechanisms.
Skin Conditions
Supporting dermal regeneration and inflammatory skin disorder research.